<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00974831</url>
  </required_header>
  <id_info>
    <org_study_id>BK51</org_study_id>
    <nct_id>NCT00974831</nct_id>
  </id_info>
  <brief_title>Glucose Tolerance in Healthy Overweight Adults</brief_title>
  <official_title>Glucose Tolerance in Healthy Overweight Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to compare the postprandial glycemic response of healthy overweight
      adults after consuming an amino acid drink mix versus a control drink.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary variable is the positive area under the curve from 0 to 180 minutes for plasma glucose.</measure>
    <time_frame>0-180 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose, insulin, C-peptide, free fatty acids, and glucagon concentration data over time</measure>
    <time_frame>0-180 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>AA Drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Amino Acid Drink Mixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucose drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Amino Acid Drink Mixture</intervention_name>
    <description>22 oz consumed in 7 oz, 8oz, 7 oz increments 5 minutes apart over 15 mins</description>
    <arm_group_label>AA Drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucose drink</intervention_name>
    <description>22 oz consumed in 7 oz, 8oz, 7 oz increments 5 minutes apart over 15 mins</description>
    <arm_group_label>Glucose drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Fasting blood glucose level of ≥ 70mg/dL and ≤ 125 mg/dL.

          2. Subject states that he/she does not have type 1 or 2 diabetes.

          3. Subject is overweight as defined as waist circumference ≥ 101 cm (40 inches) male; ≥
             88 cm (35 inches) female.

          4. Subject's BMI is ≥ 25 kg/m2.

          5. Subject's blood pressure is &lt; 140 mm Hg systolic and &lt; 90 mm Hg diastolic.

          6. Subject is between 20 and 45 years of age, inclusive.

          7. Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum
             prior to screening visit.

          8. If female is of childbearing potential, is practicing birth control

          9. If subject is on a chronic medication such as a thyroid medication or hormone therapy,
             has been on constant dosage for at least two months prior to screening visit.

        Exclusion Criteria:

          1. Subject is eating a low carbohydrate diet such as Atkins, Zone, or South Beach diet
             plan.

          2. Subject states that he/she has current infection, has had inpatient surgery, or
             corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior
             to screening visit.

          3. Subject states that he/she has an active malignancy.

          4. Subject states that he/she has had a significant cardiovascular event ≤ six months
             prior to screening visit; or stated history of congestive heart failure.

          5. Subject states that he/she has end-stage organ failure or is status post organ
             transplant.

          6. Subject states that he/she has a history of renal disease.

          7. Subject states that he/she has current hepatic disease.

          8. Subject states that he/she has a chronic, contagious, infectious disease, such as
             active tuberculosis, Hepatitis B or C, or HIV.

          9. Subject has taken/is currently taking any herbals, dietary supplements, or medications
             during the past four weeks prior to screening visit that could profoundly affect blood
             glucose.

         10. Subject has taken/is currently taking any herbals, dietary supplements, or medications
             during the past four weeks prior to screening visit to control hypertension or
             cholesterol.

         11. Subject states that he/she has clotting or bleeding disorders.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Nelson, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2009</study_first_submitted>
  <study_first_submitted_qc>September 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2009</study_first_posted>
  <last_update_submitted>November 24, 2010</last_update_submitted>
  <last_update_submitted_qc>November 24, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2010</last_update_posted>
  <responsible_party>
    <name_title>Bobbie L Swearengin, RN</name_title>
    <organization>Abbott Nutrition</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

